Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mark R, Kahn"'
Publikováno v:
The American Journal of Gastroenterology Supplements. 3:22-28
Autor:
Timothy J. Vittorio, Hassan Alkhawam, Kathleen M. Grady, Gabriel Wagman, Mohammed El-Hunjul, Mark R. Kahn, Constantine E. Kosmas
Publikováno v:
The American Journal of the Medical Sciences. 347:14-22
Many theories and clinical trials have attempted to address the effect of low-density lipoprotein (LDL) lowering in chronic congestive heart failure (CHF). The current evidence suggests that there is no convincing reason for administering statins to
Autor:
Timothy J. Vittorio, Mark R. Kahn, Constantine E. Kosmas, Kathleen M. Grady, Gregory W. Serrao, Arzhang Fallahi, Gabriel Wagman
Publikováno v:
Congestive Heart Failure. 19:85-91
Statins do not appear to have a significant benefit in heart failure (HF) as they do in coronary artery disease (CAD). Significant evidence exists that low serum cholesterol levels may be harmful in HF. This study sought to determine the optimal low-
Publikováno v:
American Journal of Transplantation. 11:2665-2674
Coronary artery disease (CAD) accounts for approximately one-half of the sizable mortality in patients with end-stage renal disease who have undergone transplantation. The study was a retrospective review of 1460 patients who underwent renal transpla
Autor:
Mark R, Kahn, Arzhang, Fallahi, Robert, Kulina, George D, Dangas, Annapoorna S, Kini, Samin K, Sharma, Michael C, Kim
Publikováno v:
The Journal of invasive cardiology. 26(3)
To compare outcomes of elective percutaneous coronary interventions (PCI) in same-day discharge and overnight hospital stays.Advances in PCI techniques and equipment have allowed same-day discharge after elective PCI. In this study, we investigated t
Publikováno v:
Nature reviews. Cardiology. 10(9)
Publikováno v:
Nature reviews. Cardiology. 10(5)
The burden of cardiovascular disease is high in patients with chronic kidney disease or end-stage renal disease. The presence of kidney dysfunction affects the cardiovascular system in multiple ways, including accelerated progression of atheroscleros
Autor:
Mark R, Kahn, Constantine E, Kosmas, Gabriel, Wagman, Gregory W, Serrao, Arzhang, Fallahi, Kathleen M, Grady, Timothy J, Vittorio
Publikováno v:
Congestive heart failure (Greenwich, Conn.). 19(2)
Statins do not appear to have a significant benefit in heart failure (HF) as they do in coronary artery disease (CAD). Significant evidence exists that low serum cholesterol levels may be harmful in HF. This study sought to determine the optimal low-
Publikováno v:
Journal of Cardiac Failure. 17:S83